Cleveland Clinic Children's Hospital launches study to genetically test for autism

February 29, 2012

Cleveland Clinic Children's Hospital has launched a study to determine whether genetic markers can be used to help identify children who are at risk of developing autism.

The study is designed to confirm the predictive value of established genetic markers and is a follow-up to retrospective studies that have been completed.

Thomas Frazier, Ph.D., of Cleveland Clinic Children's Hospital Center for , is the principle investigator for the study being funded by IntegraGen, a French biomedical company. The study will enroll 600 children over the next two years.

"This is the first time anyone has done a prospective study on a combination of to examine whether a genetic is helpful in identifying children with autism," Dr. Frazier said. "Autism is currently assessed by looking at behavioral characteristics of children. If we can develop a genetic test to assist in the earlier diagnosis of autism, we can provide beneficial treatment that leads to improved outcomes more quickly."

This study launches as the autism community prepares for the American Psychiatric Association's publication of the fifth edition of (DSM-5) in May 2013. Many experts expect the DSM will have a huge impact on by narrowing the criteria for autism, eliminating Asperger syndrome and PDD-NOS (Pervasive Developmental Disorder-Not Otherwise Specified).

"A genetic has the potential to ensure that high-functioning individuals, who are part of the autism spectrum, continue to be appropriately identified and receive necessary treatments," Dr. Frazier said.

Dr. Frazier's team will also study whether genetic changes may be associated with attention deficit/hyperactivity disorder. The study will enroll 300 children between the ages of 1 and 12 who are suspected to have an autism spectrum disorder, 75 children diagnosed with ADHD, and 225 children who do not have developmental disorders.

A cheek swab inside the mouth will be used to collect DNA from each study participant. Additionally, parents or caregivers will be asked to complete standardized questionnaires. Parents interested in finding out more information or enrolling their child in the study can contact the Cleveland Clinic Children's Hospital Center for Autism's Research Coordinator at (216) 448-6493.

The genetic testing will be done in the Genomic Medicine Institute at Cleveland Clinic's Lerner Research Institute. The study is being supported by a clinical research grant from IntegraGen, the company that developed the genetic panel being evaluated.

Explore further: DSM-5 proposed criteria for autism spectrum disorder diagnosis

Related Stories

DSM-5 proposed criteria for autism spectrum disorder diagnosis

January 23, 2012
(Medical Xpress) -- The American Psychiatric Association (APA) has proposed new diagnostic criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) for autism. While final decisions ...

Study finds wide variation in best-estimate clinical diagnosis of autism spectrum disorders

November 7, 2011
In a study conducted at 12 university-based research sites, there was wide variation in how best-estimate clinical diagnoses within the autism spectrum were assigned to individual children, according to a study being published ...

New findings validate the accuracy of autism diagnosis in children with Down syndrome

October 4, 2011
New findings from a 16-year study confirm that the Diagnostic and Statistic Manual of Mental Disorders (DSM), the gold-standard for the classification of mental health conditions, can be used to accurately identify autism ...

Higher risk of autism among certain immigrant groups

February 23, 2012
A major register study from Karolinska Institutet shows that children born to certain groups of immigrants had an increased risk of developing autism with intellectual disability. The study includes all children in Stockholm ...

Recommended for you

Potential new autism drug shows promise in mice

November 14, 2017
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the ...

Relational factors in music therapy can contribute to positive outcome for children with autism

November 6, 2017
It might not surprise that good relationships create good outcomes, as meaningful relational experiences are crucial to all of us in our everyday life. However, the development of a relationship with a child with autism may ...

In autism, too many brain connections may be at root of condition

November 2, 2017
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form ...

New autism study a "shocking wake-up call" for society, say academics

October 23, 2017
People who show characteristics of autism are more at risk of attempting suicide, according to a Coventry University study whose results are being presented to a United States federal advisory committee tomorrow.

Signaling pathway may be key to why autism is more common in boys

October 17, 2017
Researchers aiming to understand why autism spectrum disorders (ASD) are more common in boys have discovered differences in a brain signaling pathway involved in reward learning and motivation that make male mice more vulnerable ...

Whole genome sequencing identifies new genetic signature for autism

October 12, 2017
Autism has genetic roots, but most cases can't be explained by current genetic tests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.